"Those with rheumatoid arthritis and other autoimmune diseases also carry a higher risk of cardiovascular disease than those without these conditions, and the addition of GLP-1 therapy to their immunomodulating therapy may prove to be a successful combination." There are some potential risks to consider, the expert noted
Never leave GLP-1 in a hot car, direct sunlight, or unheated environments, as heat accelerates peptide degradation
The mechanism by which semaglutide provides cardiovascular protection likely involves multiple pathways, including weight reduction, improved glycemic control, and blood pressure lowering
There remains a lot to learn and know about these drugs, so it is a concern of employers, not just financial, but the health and well-being of their covered members.
Karr, T., et al